Article metrics

Download PDFPDF

Original article
Long-term efficacy and safety of secukinumab 150 mg in ankylosing spondylitis: 5-year results from the phase III MEASURE 1 extension study

 

Online download statistics by month:

Online download statistics by month: September 2019 to December 2019

AbstractFullPdf
Sep 2019527543178
Oct 2019477469169
Nov 201929629099
Dec 201922522180
Total15251523526